A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer

Cancer Chemotherapy and Pharmacology
Hugo E R FordStephen R D Johnston

Abstract

Docetaxel has significant activity in metastatic breast cancer and weekly schedules are associated with less myelosuppression than 3-weekly schedules. We evaluated the toxicity and the activity of weekly docetaxel in anthracycline-pretreated patients. A total of 42 patients were studied. Treatment consisted of docetaxel 35 mg/m2 weekly as a 30-min infusion for 6 weeks followed by a 2-week rest, with dexamethasone 8 mg i.v. pre-medication and 4 mg orally 12-hourly for 48 h following treatment. The median age of the patients was 53 years (range 34-74). Twenty-six (62%) patients had received prior chemotherapy for advanced disease. Patients received a median 10 weeks of treatment (range 1-24). 11 had a partial response (ORR 26%; 95% CI 13-39%), five of whom had relapsed <12 months since the end of previous anthracycline-based chemotherapy. In addition six patients (14%) had stable disease for >16 weeks. Myelosuppression was rare with only 2 patients (5%) experiencing grade 3 neutropenia (no grade 4 neutropenia). Non-haematological grade III toxicities were as follows: fatigue 17%, neuropathy 0%, hyperlacrimation 5%, stomatitis 7%, diarrhoea 14%, and cutaneous toxicity 19%. Skin toxicity consisted of limb/palmar-plantar erythematou...Continue Reading

References

Mar 1, 1989·Controlled Clinical Trials·R Simon
Jan 1, 1981·Cancer·A B MillerA Winkler
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D HainsworthF A Greco
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D SeidmanL Norton
Sep 25, 1999·British Journal of Cancer·O van TellingenJ H Beijnen
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H J BursteinE P Winer
May 3, 2000·The British Journal of Dermatology·C Y ChuH C Chiu
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·D H LauA T Cheung
May 11, 2001·The Oncologist·J Baselga, J M Tabernero
Aug 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D HainsworthF A Greco
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E A PerezR Patel
Dec 26, 2001·Archives of Ophthalmology·M A Ahmadi, B Esmaeli
Feb 16, 2002·Journal of Hematotherapy & Stem Cell Research·Angelo VaccaFranco Dammacco
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T AiharaY Takatsuka
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francisco J EstevaGabriel N Hortobagyi
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Simon SpazzapanAlessandro Gatti
Jan 15, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Katsumasa KuroiMasakazu Toi
Jan 18, 2003·International Journal of Cancer. Journal International Du Cancer·Derrick S GrantAdam P Dicker
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J TaberneroJ Baselga
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R GervaisE Quoix
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesP M Ravdin
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang SchuetteMonika Serke
Dec 24, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C CampsUNKNOWN Spanish Lung Cancer Group
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henri RochéBernard Asselain
Jul 11, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cesare GridelliFrancesco Perrone

❮ Previous
Next ❯

Citations

May 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ming J PoiRobert Wesolowski
May 6, 2008·Anti-cancer Drugs·Xinmiao YangXichun Hu
Jan 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carolien P SchröderPax H Willemse
Aug 30, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Lita Chew, Vivianne Shih Lee Chuen
May 21, 2019·Expert Opinion on Drug Safety·Jose Manuel Perez-Garcia, Javier Cortes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J TaberneroJ Baselga
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Akira InoueNagahiro Saijo
The New England Journal of Medicine
Joseph A SparanoNancy E Davidson
© 2021 Meta ULC. All rights reserved